当前位置:
首页>产品中心>单抗/多抗>Sibrotuzumab ELISA Kit|西布罗妥珠单抗ELISA检测试剂盒(靶标:西布罗妥珠单抗酶联免疫检测试剂盒)
Sibrotuzumab ELISA Kit|西布罗妥珠单抗ELISA检测试剂盒(靶标:西布罗妥珠单抗酶联免疫检测试剂盒)
- 货号:RB9TDC440018
- 价格:面议
- 点击:365
产品介绍
产品参数
| 应用 | ELISA |
|---|
| 检测方法 | Colorimetric |
|---|
| 灵敏度 | 0.156 μg/ml |
|---|
| 检测范围 | 0.31-5 μg/mL |
|---|
| 回收率 | 80-120% |
|---|
| 样本类型 | Plasma, Serum |
|---|
| 检测类型 | Quantitative |
|---|
| 稳定性和储存 | The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition. |
|---|
| 运输条件 | 2-8 ℃ |
|---|
| 登录号 | Q12884 |
|---|
| 背景信息 | Sibrotuzumab (also known as BIBH 1) is a humanized monoclonal antibody (mAb) which has the high affinity to bind to fibroblast activation protein (FAP), which is highly expressed by stroma cells of tumors. In addition, it was intended and developed by Boehringer Ingelheim Pharma KG for the treatment of cancer. Firstly, this drug was designed to fight against various malignancies, such as colorectal, non-small cell lung, breast, as well as head and neck cancer. However, it is disappointing that in 2003 it failed a phase II clinical trial for metastatic colorectal cancer. At present, there is no relevant clinically approved information disclosure. |
|---|
| 别名 | BIBH1, 216669-97-5 |
|---|
| 备注 | For Research Use Only. |
|---|
【仅供科学研究使用】
相关产品: